Cytotoxicity and antiviral activity of palladium(II) quinolylmethylphosphonate complexes. Synthesis of acetate complexes

Letters in Drug Design and Discovery

Volumn 3, Issue 8, 2006, Pages 528-533

  Tušek Bǒzić, Ljerka ^a   Cmrečki, Vesna ^a   Balzarini, Jan ^b   De Clercq, Erik ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Acetate complex; Antiviral activity; Cytotoxicity; Palladium complex; Phosphonate

Indexed keywords

ACETIC ACID DERIVATIVE; CHLORIDE; DIETHYL 8 QUINOLYLMETHYLPHOSPHONIC ACID; MONOETHYL 2 QUINOLYLMETHYLPHOSPHONIC ACID; PALLADIUM COMPLEX; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL GROWTH; CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 33749639798     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006778194772     Document Type: Article

References (41)

1. O'Dwyer P.J.; Stevenson P.; Johnson S.W. Clinical Status of Cisplatin, Carboplatin, and other Platinum-based Antitumor Drugs. In Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug; Lippert, B., Ed.; VHCA and Wiley-VCH: Zürich and Weinheim, 1999; pp. 31-72.
2. (a) Faraglia, G.; Fregona, D.; Sitran, S.; Giovagnini, L.; Marzano, C.; Baccichetti, F.; Casellato, U.; Graziani, R. J. Inorg. Biochem., 2001, 83, 31.
3. (b) Kovala-Demertzi, D.; Demertzis, M.A.; Filiou, E.; Pantazaki, A.A.; Yadav, P.N.; Miller, J.R.; Zheng, Y.; Kyriakidis, D. A. BioMetals, 2003, 16, 411.
4. (c) Budizisz, E.; Krajewska, U.; Rozalski, M.; Szulawska, A.; Czyz, M.; Nawrot, B. Eur. J. Pharmacol., 2004, 502, 59.
5. (d) Padhye, S.; Afrasiabi, Z.; Sinn, J.; Mehta, K.; Rath, N. Inorg. Chem., 2005, 44, 1154.
6. Nikolis, N.; Methenitis, C.; Pneumatikakis, G. J. Inorg. Biochem., 2003, 95, 177.
7. (a) Gibson, D.; Mansur, N.; Gean, K.F. J. Inorg. Biochem., 1995, 58, 79.
8. (b) Lee, H.H.; Palmer, B.D.; Baguley, B.C.; Chin, M.; McFadyen, W.D.; Wickham, G.; Thorsbourne-Palmer, D.; Wakelin, L.P.G.; Denny, W.A. J. Med. Chem., 1992, 35, 2983.
9. (c) Sachinvala, N.D.; Chen, H.; Niemczura, W.P.; Furusawa, E.; Cramer, R.E.; Rupp, J.J.; Ganjin, I. J. Med. Chem., 1993, 36, 1791.
10. (a)Klenner, T.; Valenzuela-Paz, P.; Amelung, F.; Munch, H.; Zahn, H.; Keppler, B.K.; Blum, H. Platinum Phosphonato Complexes with Particular Activity Against Bone Malignancies. An Evaluation of an Experimental Model Highly Predictive for the Clinical Situation. In Metal Complexes in Cancer Chemotherapy; Keppler, B.K., Ed.; VCH: Weinheim, 1993; pp. 85-127.
11. (b) Brzezinska-Blaszczyk, E.; Mincikiewicz, M.; Ochocki, J. Eur. J. Pharmacolog., 1996, 298, 155.
12. (c) Bloemink, M.J.; Diederen, J.H.; Dorenbos, J.P.; Heeterbij, R.J.; Keppler, B.K.; Reedijk, J. Eur. J. Inorg. Chem., 1999, 10, 1655.
13. (d) Budizisz, E.; Graczyk-Wojciechowska, J.; Zieba, R.; Nawrot, B. New J. Chem., 2002, 26, 1799.
14. (a) Tušek-Božić, Lj.; Matijašić, I.; Bocelli, G.; Calestani, G.; Furlani, A.; Scarcia, V.; Papaioannou, A. J. Chem. Soc., Dalton. Trans., 1991, 195.
15. (b) Ćurić, M.; Tušek-Božić, Lj.; Vikić-Topić, D.; Scarcia, V.; Furlani, A.; Balzarini, J.; De Clercq, E. J. Inorg. Biochem., 1996, 63, 125.
16. (a) Tušek-Božić, Lj.; Matijašić, I.; Bocelli, G.; Sgarabotto, P.; Furlani, A.; Scarcia, V.; Papaioannou, A. Inorg. Chim. Acta, 1991, 185, 229.
17. (b) Tušek-Božić, Lj.; Trojko, R. Thermochim. Acta, 1991, 339, 41.
18. Tušek-Božić, Lj.; Furlani, A.; Scarcia, V.; De Clercq, E.; Balzarini, J. J. Inorg. Biochem., 1998, 72, 201.
19. Tušek-Božić, Lj.; Komac, M.; Ćurić, M.; Lyčka, A.; D'Alpaos, M.; Scarcia, V.; Furlani, A. Polyhedron, 2000, 19, 937.
20. Tušek-Božić, Lj.; Frausin, F.; Scarcia, V.; Furlani, A. J. Inorg. Biochem., 2003, 95, 259.
21. Tušek-Božić, Lj.; D'Alpaos, M. Polyhedron, 1998, 17, 1481.
22. (a) Nakamoto, K. Infared and Raman Spectra of Inorganic and Coordination Compounds, Part B: Applications in Coordination Organometallic and Bioinorganic Chemistry; 5th ed., Willey-Interscience, 1997.
23. (b) Zurowska, B.; Ochocki, J.; Mriziñski, J.; Ciunik, Z.; Reedijk, J. Inorg. Chim. Acta., 2004, 357, 755.
24. (a) Thomas, L.C. Intrepertation of Infrared Spectra of Organophosphorus Compounds, Plenum: New York, 1974.
25. (b) Tušek-Božić, Lj. Vib. Spectrosc., 2002, 28, 235.
26. (a) Stang, P.J.; Olenyuk, B.; Arif, A.M. Organometallics, 1995, 14, 5281.
27. (b) Bierbach, U.; Farrell, N. Inorg. Chem., 1997, 36, 3657.
28. (c) Scolaro, R.M.; Mazzaglia, A.; Romeo, A.; Plutino, M.R.; Castriciano, M.; Romeo, R. Inorg. Chim. Acta, 2002, 330, 189.
29. (a) Tušek-Božić, Lj.; Lyčka, A. Magn. Reson. Chem., 2002, 40, 175.
30. (b) Tušek-Božić, Lj.; Ćurić, M.; Vikić-Topić, D.; Lyčka, A. Collect. Czech. Chem. Commun., 1997, 62, 1888.
31. (c) Tuśek-Božić, Lj.; D'Alpaos, M.; Ćurić, M.; Lyčka, A. Croat. Chem. Acta, 2001, 74, 825.
32. Mason, N.J.; Geary W.J.; Nixon, L.A.; Nowell, W. J. Chem. Soc., Dalton Trans., 1986, 1347.
33. De Clercq, E.; Balzarini, J.; Torrence, P.F.; Mertes, M.P.; Schmidt, C.L.; Shugar, D.; Barr, P.J.; Jones, A.S.; Verhelst, G.; Walker, R.T. Mol. Pharmacol., 1981, 19, 321.
34. (a) Souchard, J.P.; Ha, T.T.; Cros, S.; Johnson, N.P. J. Med. Chem., 1991, 34, 863.
35. (b) Reedijk, J. Chem. Commun., 1996, 801.
36. Lee, Y.A.; Chung, Y.K.; Sohn, Y.S. J. Inorg. Biochem., 1997, 68, 289.
37. (a) Higgins, J.D.; Neely, L.; Fricker, S.; Matthey J. J. Inorg. Biochem., 1993, 49, 149.
38. (b) Navarro-Ranninger, C.; López-Solera, I.; González, V.M.; Pérez, J.M.; Alvarez-Valdés, A.; Martin, A.; Raithby, P.R.; Masaguer, J.R.; Alonso, C. Inorg. Chem., 1996, 35, 5181.
39. (c) Zamora, F.; Rico, S.; Amo-Ochoa, P. J. Inorg. Biochem., 1997, 68, 257.
40. Fakih, S.; Tung, W.C.; Eierhoff, D.; Mock, C.; Krebs, B. Z. Anorg. Allg. Chem., 2005, 631, 1397.
41. De Clercq, E. In In Vitro and Ex Vivo Test Systems to Rationalize Drug Design and Delivery; Crommelin, D.; Couvreur, P.; Duchêne, D., Ed.; Editions de Santé: Paris, 1994; pp. 108-125.